NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Insert as subheadline: NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED...
ZYUS Life Sciences Corporation (“ZYUS” or the “Company”) (TSXV: ZYUS) is pleased to announce that Brent Zettl, President and CEO of ZYUS, will present and host one-on-one meetings with investors...
ZYUS Receives Patent from United States Patent and Trademark Office (“USPTO”) Supporting ZYUS’ Lead Drug Candidate ZYUS Life Sciences Corporation (the “Company”) (TSX-V: ZYUS), a Canadian-based...
Dr. Clarke Joins ZYUS’ Clinical Advisory Committee, Bringing Extensive Expertise in Healthcare and Pain Management ZYUS Life Sciences Corporation (the “Company”) (TSX-V: ZYUS), a Canadian-based...
Scott Livingstone brings extensive healthcare expertise and strategic leadership to ZYUS’ experienced team ZYUS Life Sciences Corporation (the “Company”) (TSX-V: ZYUS), a Canadian-based life...
Evaluating Efficacy, Safety, and Tolerability in Patients with Moderate to Severe Cancer-Related Pain ZYUS Life Sciences Corporation ("ZYUS" or the “Company”) (TSX-V: ZYUS), a Canadian-based life...
Completion of Phase 1 and Supportive Preclinical Data Will Assist in Ongoing Phase 2 Clinical Development of ZYUS’ Lead Drug Product Candidate ZYUS Life Sciences Corporation ("ZYUS" or the...
Mr. Miller brings nearly two decades of knowledge, experience and expertise to ZYUS ZYUS Life Sciences Corporation ("ZYUS" or the “Company”) (TSX-V: ZYUS), a Canadian-based life sciences company...
ZYUS Life Sciences Corporation ("ZYUS" or the “Company”) (TSX-V: ZYUS), a Canadian-based life sciences company leading scientific research and global development of innovative cannabinoid-based...
Mr. Brownlee brings more than 30 years of knowledge, experience and expertise to ZYUS’ Board of Directors ZYUS Life Sciences Corp. ("ZYUS" or the “Company”) (TSX-V: ZYUS), a Canadian-based life...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.12 | -13.0434782609 | 0.92 | 0.92 | 0.8 | 2170 | 0.81953917 | CS |
4 | -0.05 | -5.88235294118 | 0.85 | 1 | 0.75 | 3323 | 0.88118614 | CS |
12 | -0.07 | -8.04597701149 | 0.87 | 1 | 0.7 | 3501 | 0.82561408 | CS |
26 | -0.21 | -20.7920792079 | 1.01 | 1.05 | 0.7 | 3902 | 0.87738212 | CS |
52 | -0.11 | -12.0879120879 | 0.91 | 1.19 | 0.7 | 5701 | 0.9528505 | CS |
156 | -1.7 | -68 | 2.5 | 2.5 | 0.7 | 9313 | 1.0999959 | CS |
260 | -1.7 | -68 | 2.5 | 2.5 | 0.7 | 9313 | 1.0999959 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales